Core Laboratories
CLB
345 hedge funds and large institutions have $5.32B invested in Core Laboratories in 2014 Q4 according to their latest regulatory filings, with 63 funds opening new positions, 116 increasing their positions, 118 reducing their positions, and 57 closing their positions.
11% more first-time investments, than exits
New positions opened: 63 | Existing positions closed: 57
9.15% more ownership
Funds ownership: 91.73% → 100.88% (+9.1%)
0% more funds holding
Funds holding: 344 → 345 (+1)
2% less repeat investments, than reductions
Existing positions increased: 116 | Existing positions reduced: 118
11% less capital invested
Capital invested by funds: $5.98B → $5.32B (-$656M)
71% less funds holding in top 10
Funds holding in top 10: 7 → 2 (-5)
76% less call options, than puts
Call options by funds: $14.9M | Put options by funds: $62.8M
Top Buyers
| 1 |
WP
Wedgewood Partners
St Louis,
Missouri
|
+$292M |
| 2 |
ClearBridge Investments
New York
|
+$224M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$69.9M |
| 4 |
Bessemer Group
Woodbridge,
New Jersey
|
+$63.7M |
| 5 |
JSP
Jackson Square Partners
Larkspur,
California
|
+$56.4M |
Top Sellers
| 1 |
VAM
Vontobel Asset Management
New York
|
-$151M |
| 2 |
Goldman Sachs
New York
|
-$86.4M |
| 3 |
Jennison Associates
New York
|
-$51.9M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$46.8M |
| 5 |
CC
Capital Counsel
New York
|
-$39.2M |
CLB Hedge Fund Activity: Q4 2014 in Review
345 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q4 2014, worth a combined $5.32B — down 11% from $5.98B a quarter earlier.
Buyers outnumbered sellers: 63 funds opened new CLB positions and 57 closed out — a net gain of 6 holders — while 116 added to existing stakes and 118 trimmed.
The largest buyer was Wedgewood Partners, opening a new position worth an estimated $292M. The largest seller was Vontobel Asset Management, cutting an estimated $151M.
- 345 institutional investors held Core Laboratories (CLB) as of Q4 2014, up from 344 in Q3 2014.
- Funds reported $5.32B of Core Laboratories stock for Q4 2014, down 11% quarter-over-quarter.
- 63 funds opened new Core Laboratories positions in Q4 2014 and 57 closed out, a net change of +6 holders.
- The largest Core Laboratories buyer in Q4 2014 was Wedgewood Partners, an estimated $292M added.
- The largest Core Laboratories seller in Q4 2014 was Vontobel Asset Management, an estimated $151M sold.
Based on aggregated 13F filings for Q4 2014.